CoChat

Screening for Coronary Artery Disease in Patients With Diabetes

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.

Abstract

Coronary artery disease (CAD) accounts for a large fraction of the morbidity, mortality, and cost of diabetes. Recognizing this, nearly 10 years ago the American Diabetes Association published a consensus recommendation that clinicians consider a risk factor–guided screening approach to early diagnosis of CAD in both symptomatic and asymptomatic patients. Subsequent clinical trial results have not supported those recommendations. Since the prior consensus statement, newer imaging methods, such as coronary artery calcium scoring and noninvasive angiography with computed tomography (CT) techniques, have come into use. These technologies, which allow quantitation of atherosclerotic burden and can predict risk of cardiac events, might provide an approach to more widespread coronary atherosclerosis screening. However, over this same time interval, there has been recognition of diabetes as a cardiovascular disease (CVD) equivalent, clear demonstration that medical interventions should provide primary and secondary CVD risk reduction in diabetic populations, and suggestive evidence that percutaneous coronary revascularization may not provide additive survival benefit to intensive medical management in patients with stable CAD. This additional evidence raises the question of whether documenting asymptomatic atherosclerosis or ischemia in people with diabetes is warranted. More data addressing this issue will be forthcoming from the BARI 2-D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. Until then, for patients with type 2 diabetes who are asymptomatic for CAD, we recommend that testing for atherosclerosis or ischemia, perhaps with cardiac CT as the initial test, be reserved for those in whom medical treatment goals cannot be met and for selected individuals in whom there is strong clinical suspicion of very-high-risk CAD. Better approaches to identify such individuals based on readily obtained clinical variables are sorely needed.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc07-9927

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 69 references

Cited by

See all 251

Metadata

Authors
Bax, J. J., Young, L. H., Frye, R. L., Bonow, R. O., Steinberg, H. O., & Barrett, E. J.
Affiliations
  • Leiden University Medical Center (NL)
  • Yale University (US)
  • Mayo Clinic (US)
  • Northwestern University (US)
  • Indiana University Indianapolis (US)
  • University of Virginia (US)
Venue
Diabetes Care
Published
2007-10-01
Volume
30
Issue
10
Pages
2729-2736
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2108913002
Cited by
251
References
71
Citations by year
2026: 2 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 11 · 2015: 11 · 2014: 16 · 2013: 23 · 2012: 15
FWCI
17.46
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords
coronary artery disease, diabetes mellitus, cardiovascular risk screening, coronary artery calcium scoring, cardiac CT angiography, atherosclerosis, type 2 diabetes, asymptomatic coronary artery disease, percutaneous coronary intervention, cardiovascular risk reduction
MeSH terms
Coronary Disease, Diabetic Angiopathies, Diabetic Neuropathies, Diabetic Retinopathy, Humans, Hyperglycemia, Mass Screening, Risk Assessment, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for Coronary Artery Disease in Patients With Diabetes. https://app.cochat.ai/papers/10.2337/dc07-9927
The paper
Bax, J. J., Young, L. H., Frye, R. L., Bonow, R. O., Steinberg, H. O., & Barrett, E. J. (2007). Screening for Coronary Artery Disease in Patients With Diabetes. Diabetes Care. https://doi.org/10.2337/dc07-9927

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.